This panel session explored the sensitive, lucrative, and increasingly important role of health care data. Participants were able to:
- Learn what to expect under the Trump administration and new FTC Commissioner Acting Chairman Maureen Ohlausen about FTC authority over data privacy/security and implications for companies of all sizes, from internet giants to small businesses.
- Hear what health care companies need to do to protect health-care information beyond meeting HIPAA security requirements potential enforcement collaborations.
- Understand the practical implications of the LabMD litigation in the 11th Circuit – which challenges FTC enforcement over cybersecurity issues.